Get the Stockscreener App
19.25
1.94%
-0.38
Abrdn Life Sciences Investors stock is traded at $19.25, with a volume of 445.03K.
It is down -1.94% in the last 24 hours and up +1.91% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
See More
Previous Close:
$19.63
Open:
$19.44
24h Volume:
445.03K
Relative Volume:
3.64
Market Cap:
$585.35M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.48%
1M Performance:
+1.91%
6M Performance:
+11.53%
1Y Performance:
+44.41%
1-Day Range:
$19.03
$19.60
1-Week Range:
$19.03
$20.05
52-Week Range:
$13.01
$21.32
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL vs DNP, UTG, ADX, UTF, AADX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
19.25 | 585.35M | 0 | 0 | 0 | 0.00 |
DNP
Dnp Select Income Fund Inc
|
11.10 | 4.18B | 0 | 0 | 0 | 0.00 |
UTG
Reaves Utility Income Fund
|
40.04 | 3.69B | 0 | 0 | 0 | 0.00 |
ADX
Adams Diversified Equity Fund
|
25.88 | 3.17B | 0 | 0 | 0 | 0.00 |
UTF
Cohen Steers Infrastructure Fund Inc
|
28.07 | 3.14B | 0 | 0 | 0 | 0.00 |
AADX
Adams Diversified Equity Fund
|
18.01 | 3.08B | 522.09M | -24.84M | 0 | -0.1455 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
abrdn Healthcare Investors (NYSE:HQH) Sees Strong Trading VolumeHere's Why - MarketBeat
Director Chris Mahai Acquires Shares in abrdn Healthcare Investo - GuruFocus
Insider Buying: Chris Mahai Acquires Shares of abrdn Life Sciences Investors (HQL) - GuruFocus
Director Chris Mahai buys 527 abrdn Life Sciences (NYSE: HQL) shares - Stock Titan
abrdn Healthcare Investors director Mahai Chris LaVictoire acquires $10,500.96 in common shares - Bitget
abrdn Life Sciences Investors (NYSE:HQL) Hits New 52-Week HighStill a Buy? - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update - MarketBeat
NYSE New 52-Week Highs And Lows - Moomoo
Fed Minutes Reveal Significant Disagreement on Interest Rate PathReturn On Equity - Bölüm Sonu Canavarı
abrdn Life Sciences Investors (HQL) Rallies 2.38% as Sector Sentiment ImprovesDividend Arbitrage - dars.gov.et
THWabrdn World Healthcare Fund Website Traffic and Mobile Apps Usage - Finviz
abrdn Healthcare Opportunities Fund offers high... - Pluang
THQ: A Solid Healthcare Fund For 2026 (NYSE:THQ) - Seeking Alpha
Press Release: Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - Moomoo
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - TradingView
abrdn Life Sciences Investors (HQL) Advances 0.83% as Life Sciences Sector Shows StrengthMFI Divergence - dars.gov.et
abrdn Healthcare Investors (HQH) Edges Higher: Testing Key Resistance Near $20.50Volatility Breakout Picks - newsline.com
abrdn Healthcare Investors (HQH) Advances 1.44% as Sector Fund Tests Key Resistance ZoneHidden Order - newsline.com
abrdn Healthcare Opportunities Fund (THQ) Edges Higher Amid Sector StabilityGap and Go - newsline.com
New abrdn Life Sciences (NYSE: HQL) director files initial Form 3 - Stock Titan
Mahai Chris LaVictoire joins abrdn Healthcare (HQH) as reporting insider - Stock Titan
Abrdn Life Sciences Investors Reports Earnings Results for the Half Year Ended March 31, 2026 - marketscreener.com
Abrdn Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2026 - marketscreener.com
abrdn Healthcare Investors (HQH) Dips 2.74% as Sector Rotation Pressures the Closed-End FundConversion Trade - dars.gov.et
HQHabrdn Healthcare Investors Stock Price and Quote - Finviz
THQabrdn Healthcare Opportunities Fund Stock Price and Quote - Finviz
THQ Surges 1.69%: Healthcare Fund Breaks Above Key Support LevelsFactor Valuation - newsline.com
Aberdeen Investments U.S. Closed-End Funds Announce Results Of Annual Meeting Of Shareholders - Weekly Voice
ION closes the gap between trading and pipeline execution across North American gas markets with NatGasHub.com - Weekly Voice
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF A - GuruFocus
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS – Company Announcement - Financial Times
PWRL Stock Price and Chart — NASDAQ:PWRL - TradingView
abrdn Life Sciences Investors (HQL) Gains 0.92% as Momentum Builds Near Key ResistanceFlat Correction - dars.gov.et
abrdn Healthcare Investors (HQH) Slightly Lower as Shares Test Key Support LevelsWyckoff Accumulation - Newser
abrdn World Healthcare Fund Q1 2026 Commentary - Seeking Alpha
abrdn Life Sciences Investors (HQL) Edges Higher as Sector Rotations Lift Healthcare-Focused CEFEquity Put Call - Newser
abrdn Life Sciences Investors (HQL) Edges Higher, Approaching ResistancePrice Momentum Stocks - Newser
Abrdn Life Sciences Investors: - marketscreener.com
abrdn Life Sciences Investors Q1 2026 Commentary - Seeking Alpha
HQH: Growth Potential Limited But Portfolio Structure (NYSE:HQH) - Seeking Alpha
HQL: Attractive Outlook With Growth Of GLP-1 Market (NYSE:HQL) - Seeking Alpha
abrdn Life Sciences Investors Fund offers 12.6% yield at 8.49% NAV discount, ideal for income-focused investors. - Pluang
Abrdn Healthcare Opportunities Fund Q1 2026 Commentary (NYSE:THQ) - Seeking Alpha
Abrdn Healthcare Investors Q1 2026 Commentary (NYSE:HQH) - Seeking Alpha
abrdn Healthcare Investors (HQH) Declares $0.61 Quarterly Divide - GuruFocus
Abrdn Life Sciences Investors To Go Ex-Dividend On May 21st, 2026 With 0.56 USD Dividend Per Share - Moomoo
HQL (abrdn Life) life sciences investment trust holds quarterly distribution amid biotech sector volatility.Profit Guidance - Newser
Press Release: Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts - Moomoo
THQ (abrdn) Healthcare Opportunities Fund evaluates portfolio positioning as healthcare sector conditions shift.Trending Entry Points - Newser
Aberdeen Investments announces May and June 202... - Pluang
BOT Stock Fund Price and Chart — NASDAQ:BOT - TradingView
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.68%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):